NCT00002681View on ClinicalTrials.gov

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 1995

Primary Completion Date

September 30, 2003

Study Completion Date

December 31, 2003

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

daclizumab

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Roger Williams Medical Center

OTHER